Yannick Simoni

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Integrated analysis of post-transcriptional regulations reveals insights into acute myeloid leukemia.⚑
  2025 L1 32/100 ⚑

1 assessed by us (0 reproduced) · 80 not yet assessed — every PubMed paper on record, linked below.

• An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model ↗

  Molecular Therapy · 2026 · PMID 41935953
  not yet assessed
• High frequency of <scp>CD95</scp> ⁺ / <scp>CD45RA</scp> ⁻ regulatory T cells defines an immunosuppressive profile associated with <scp>MDS</scp> progression ↗

  British Journal of Haematology · 2026 · PMID 42080308
  not yet assessed
• An <i>in vivo</i> CRISPR screen unveils top target genes to improve CAR-T cell efficacy in a solid tumor model ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2025
  not yet assessed
• Pro-inflammatory role of granzyme K producing bystander CD8 ⁺ T cells in acute myeloid leukemia ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2025
  not yet assessed
• RAPID FIRE SESSION 01 ↗

  Leukemia Research · 2025
  not yet assessed
• MDS BIOLOGY AND PATHOGENESIS - IMMUNE DEREGULATION / INFLAMMATION ↗

  Leukemia Research · 2025
  not yet assessed
• Integrated analysis of post-transcriptional regulations reveals insights into acute myeloid leukemia⚑

  Communications Biology · 2025 · PMID 41407883
  L1 32/100 ⚑
• An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2025
  not yet assessed
• An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2025
  not yet assessed
• Immune‐monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium ↗

  HemaSphere · 2024 · PMID 38756352
  not yet assessed
• Stem-like exhausted CD8 T cells in pleural effusions predict improved survival in non-small cell lung cancer (NSCLC) and mesothelioma ↗

  Translational Lung Cancer Research · 2024 · PMID 39430319
  not yet assessed
• In-depth analysis of human virus-specific CD8+ T cells delineates unique phenotypic signatures for T cell specificity prediction ↗

  Cell Reports · 2023 · PMID 37837618
  not yet assessed
• Figure S3 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma ↗

  2023
  not yet assessed
• Figure S4 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma ↗

  2023
  not yet assessed
• Supplementary figure legends from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma ↗

  2023
  not yet assessed
• Figure S4 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma ↗

  2023
  not yet assessed
• Figure S5 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma ↗

  2023
  not yet assessed
• Figure S5 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma ↗

  2023
  not yet assessed
• Figure S6 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma ↗

  2023
  not yet assessed
• Figure S6 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma ↗

  2023
  not yet assessed
• Supplementary figure legends from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma ↗

  2023
  not yet assessed
• Figure S3 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma ↗

  2023
  not yet assessed
• Data from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma ↗

  2023
  not yet assessed
• Figure S2 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma ↗

  2023
  not yet assessed
• Figure S1 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma ↗

  2023
  not yet assessed
• Figure S1 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma ↗

  2023
  not yet assessed
• Figure S2 from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma ↗

  2023
  not yet assessed
• S169: MODULATION OF THE IMMUNE LANDSCAPE IN LOWER-RISK MYELODYSPLASTIC SYNDROMES WITH IMETELSTAT-INDUCED TRANSFUSION INDEPENDENCY ↗

  HemaSphere · 2023
  not yet assessed
• Data from Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma ↗

  2023
  not yet assessed
• Bystander CD4 ⁺ T cells infiltrate human tumors and are phenotypically distinct ↗

  OncoImmunology · 2022 · PMID 36524209
  not yet assessed
• NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome ↗

  Journal for ImmunoTherapy of Cancer · 2022 · PMID 35768164
  not yet assessed
• Diagnosis of Myelodysplastic Syndromes: From Immunological Observations to Clinical Applications ↗

  Diagnostics · 2022 · PMID 35885563
  not yet assessed
• Intratumoral CD39+CD8+ T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLC ↗

  Journal of Thoracic Oncology · 2021 · PMID 33975004
  not yet assessed
• Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies ↗

  Proceedings of the National Academy of Sciences · 2021 · PMID 34285073
  not yet assessed
• Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity ↗

  Nature Communications · 2020 · PMID 32709874
  not yet assessed
• A Targeted Multi-omic Analysis Approach Measures Protein Expression and Low-Abundance Transcripts on the Single-Cell Level ↗

  Cell Reports · 2020 · PMID 32268080
  not yet assessed
• Human Tumor-Infiltrating MAIT Cells Display Hallmarks of Bacterial Antigen Recognition in Colorectal Cancer ↗

  Cell Reports Medicine · 2020 · PMID 33205061
  not yet assessed
• Partial absence of PD‐1 expression by tumor‐infiltrating EBV‐specific CD8⁺ T cells in EBV‐driven lymphoepithelioma‐like carcinoma ↗

  Clinical & Translational Immunology · 2020 · PMID 32995000
  not yet assessed
• Ontogeny of different subsets of yellow fever virus-specific circulatory CXCR5+ CD4+ T cells after yellow fever vaccination ↗

  Scientific Reports · 2020 · PMID 32973217
  not yet assessed
• Bystander CD4 ⁺ T cells infiltrate human tumors and are phenotypically distinct ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2020
  not yet assessed
• High-dimensional profiling of tumor-infiltrating CD4+T cells in Human cancer: Are they all tumor-specific? ↗

  The Journal of Immunology · 2020
  not yet assessed
• Unsuccessful checkpoint blockade and vaccination therapy despite expansion of tumor neoantigen-specific CD8 T cells in the Lewis Lung Carcinoma (LLC) model ↗

  The Journal of Immunology · 2020
  not yet assessed
• Profiling antigen specificity concurrently with protein and mRNA quantification using high throughput single-cell multiomics reveal surprising similarities between bystander and tumor specific CD8⁺ tumor-infiltrating lymphocytes (TILs) in renal cell carcinoma (RCC). ↗

  Journal of Clinical Oncology · 2020
  not yet assessed
• Antigen-specificity/protein/mRNA single-cell sequencing profiling of bystander CD8+tumor-infiltrating lymphocytes (TILs) in renal cell carcinoma (RCC) reveals their transcriptomic similarities with tumor-specific T cells ↗

  The Journal of Immunology · 2020
  not yet assessed
• A Subset of Type I Conventional Dendritic Cells Controls Cutaneous Bacterial Infections through VEGFα-Mediated Recruitment of Neutrophils ↗

  Immunity · 2019 · PMID 30926233
  not yet assessed
• Multiplex MHC Class I Tetramer Combined with Intranuclear Staining by Mass Cytometry ↗

  Methods in molecular biology · 2019 · PMID 31077105
  not yet assessed
• A targeted multi-omic analysis approach measures protein expression and low abundance transcripts on the single cell level ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2019
  not yet assessed
• Partial absence of PD-1 expression by tumor-specific CD8 ⁺ T cells in EBV-driven lymphoepithelioma-like carcinoma: a case report ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2019
  not yet assessed
• A Targeted Multi-Omic Analysis Approach Measures Protein Expression and Low Abundance Transcripts on the Single Cell Level ↗

  SSRN Electronic Journal · 2019
  not yet assessed
• Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates ↗

  Nature · 2018 · PMID 29769722
  not yet assessed
• Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma ↗

  Cancer Research · 2018 · PMID 29531161
  not yet assessed
• CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells ↗

  Frontiers in Immunology · 2018 · PMID 29686665
  not yet assessed
• Mass cytometry: a powerful tool for dissecting the immune landscape ↗

  Current Opinion in Immunology · 2018 · PMID 29655022
  not yet assessed
• Mapping of γ/δ T cells reveals Vδ2+ T cells resistance to senescence ↗

  EBioMedicine · 2018 · PMID 30528453
  not yet assessed
• Adaptive NKG2C+CD57+ Natural Killer Cell and Tim-3 Expression During Viral Infections ↗

  Frontiers in Immunology · 2018 · PMID 29731749
  not yet assessed
• Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency ↗

  Immunity · 2018
  not yet assessed
• Reverse-engineering flow-cytometry gating strategies for phenotypic labelling and high-performance cell sorting ↗

  Bioinformatics · 2018 · PMID 29931307
  not yet assessed
• Un marqueur de surface pour identifier les lymphocytes T CD8 spécifiques de tumeurs ↗

  médecine/sciences · 2018 · PMID 30623762
  not yet assessed
• Reverse-engineering flow-cytometry gating strategies for phenotypic labelling and high-performance cell sorting ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2018
  not yet assessed
• Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells ↗

  Nature Communications · 2018 · PMID 30050138
  not yet assessed
• ACTR-20. A SMALL MOLECULE AXL INHIBITOR, BGB324 – FIRST-IN-HUMAN GBM SURGICAL PK TRIAL FOR RECURRENT TUMORS ↗

  Neuro-Oncology · 2018
  not yet assessed
• Mapping of γ/δ T cells Reveals Vδ2 T cells Resistance to Senescence ↗

  SSRN Electronic Journal · 2018
  not yet assessed
• CD161 defines a functionally distinct subset of pro-inflammatory natural killer cells

  Open MIND · 2018
  not yet assessed
• Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells ↗

  Nature Communications · 2017 · PMID 28916749
  not yet assessed
• Toward Meaningful Definitions of Innate-Lymphoid-Cell Subsets ↗

  Immunity · 2017 · PMID 28514678
  not yet assessed
• Multiplex peptide-MHC tetramer staining using mass cytometry for deep analysis of the influenza-specific T-cell response in mice ↗

  Journal of Immunological Methods · 2017 · PMID 28974367
  not yet assessed
• Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency ↗

  Immunity · 2016 · PMID 27986455
  not yet assessed
• Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression ↗

  Immunity · 2016 · PMID 26850658
  not yet assessed
• Plasmacytoid dendritic cells license regulatory T cells, upon iNKT‐cell stimulation, to prevent autoimmune diabetes ↗

  European Journal of Immunology · 2014 · PMID 24481989
  not yet assessed
• Invariant NKT cell development: focus on NOD mice ↗

  Current Opinion in Immunology · 2014 · PMID 24637104
  not yet assessed
• Rôle des cellules immunitaires innées dans le diabète de type 1 ↗

  Diabetes & Metabolism · 2014
  not yet assessed
• Rôle régulateur des lymphocytes NKT dans la prévention du diabète de type 1 ↗

  médecine/sciences · 2013 · PMID 24005626
  not yet assessed
• L’immunité innée dans le diabète sucré ↗

  2013
  not yet assessed
• Innate immunity in diabetes mellitus

  theses.fr (ABES) · 2013
  not yet assessed
• L’immunité innée dans le diabète sucré ↗

  2013
  not yet assessed
• Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes ↗

  Nature Medicine · 2012 · PMID 23242473
  not yet assessed
• Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality? ↗

  Clinical & Experimental Immunology · 2012 · PMID 23199318
  not yet assessed
• Prevention or acceleration of type 1 diabetes by viruses ↗

  Cellular and Molecular Life Sciences · 2012 · PMID 22766971
  not yet assessed
• Erratum to: Prevention or acceleration of type 1 diabetes by viruses ↗

  Cellular and Molecular Life Sciences · 2012
  not yet assessed
• NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes ↗

  European Journal of Immunology · 2011 · PMID 22002883
  not yet assessed
• NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes

  2011
  not yet assessed